We are monitoring the impact of COVID-19 on MEA Hormone Replacement Therapy Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 902
Share on
Share on

Middle East & Africa Hormone Replacement Therapy Market Research Report - SegmentedBy Hormone Type, By Route Of Administration & By Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2021 to 2026)

Pulished: April, 2021
ID: 902
Pages: 130

MEA Hormone Replacement Therapy Market Size & Growth (2021 to 2026):

As per the research report, the size of the Middle East and Africa Hormone Replacement Therapy Market is valued at USD 1.17 billion in 2021 and is predicted to reach USD 1.66 billion by 2026, growing at a CAGR of 7.24% during the forecast period 2021 to 2026.

Hormone replacement therapy (HRT) is a treatment used to relieve symptoms of the menopause. It replaces hormones that are at a lower level as women approach the menopause. These days, hormone therapy is even employed in the treatment of other health conditions like male hypogonadism, growth hormone deficiency, hypothyroidism, etc.

The key growth driver for the hormone replacement therapy market in the Middle-East region is the increasing awareness about post-menopausal problems amongst women. The other noteworthy growth drivers are availability and development novel formulations, presence of unmet medical needs which require the employment of hormone therapy, etc. Coming to the African countries, the market here at present is merely low but given the demographic advantage, it can pick up within the next 10 years.

Along with a lack of awareness about the HRT benefits, the other major factor acting as a hurdle for market growth is the cost of therapy, especially in the African countries. Usually, the hormone therapy costs around $ 10,000. This is a huge amount considering the economic conditions of people in most of the countries in the African region. Further, the risk of side effects, such as bloating, mood changes, and nausea, bleeding, breast tenderness or enlargement, headaches, risk of breast cancer, heart disease, and stroke is restraining the growth of HRT market in both Middle-East and African countries. Along with this, women with high susceptibility to coronary diseases are kept away from taking hormone replacement therapy.

This research report segmented and sub-segmented into the following categories:

  • By Hormone Type: Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, Thyroid replacement therapy, and others.
  • By Route of Administration: Oral, transdermal, parenteral, and other routes.
  • By Country:  KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

Moreover, on the basis of geography, the Middle-East & Africa hormone replacement therapy market is analyzed under the Middle East and Africa regions considering the major countries.

The leading companies leading in the MEA Hormone Replacement Therapy Market profiled in the report are Novartis, Abbott Laboratories, Pfizer, Mylan Laboratories, F. Hoffmann-La Roche, Merck & Co, Amgen, Eli Lily, Bayer, Novo Nordisk, Wyeth, Hisamitsu Pharmaceutical Co. Inc

1.Introduction         

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions                                

2. Research Methodology                  

                2.1 Introduction     

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                            

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                     

                                2.2.4 Expert Validation                  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview             

                3.1 Executive Summary                                

                3.2 Key Inferences

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)             

                4.1 Market Drivers 

                4.2 Market Restraints                                    

                4.3 Key Challenges

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                     

                 5.1 By Hormone Type                                   

                                5.1.1 Estrogen Replacement Therapy                     

                                5.1.2 Growth Hormone Replacement Therapy                   

                                5.1.3 Thyroid Replacement Therapy                       

                                5.1.4 Others                      

                5.2 By Route of Administration                                 

                                5.2.1 Oral                            

                                5.2.2 Parenteral               

                                5.2.3 Transdermal                           

                                5.2.4 Others                      

6. Geographical Analysis                     

                6.1 Introduction     

                6.2 Middle-East       

                6.3 Africa   

7. Pipeline Product Analysis              

                7.1 Overview           

                7.2 Pipeline Development Landscape           

                7.3 Molecular Targets in the Pipeline            

                7.4 Clinical Trials    

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target                       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                                  

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.                               

8.Strategic Analysis               

                8.1 PESTLE analysis

                                8.1.1 Political                     

                                8.1.2 Economic                 

                                8.1.3 Social                         

                                8.1.4 Technological                         

                                8.1.5 Legal                          

                                8.1.6 Environmental                      

                8.2 Porter’s Five analysis     

                                8.2.1 Bargaining Power of Suppliers                        

                                8.2.2 Bargaining Power of Consumers                    

                                8.2.3 Threat of New Entrants                     

                                8.2.4 Threat of Substitute Products and Services               

                                8.2.5 Competitive Rivalry within the Industry                      

9.Market Leaders' Analysis                 

                9.1 Abbott Laboratories                               

                                9.1.1 Overview                

                                9.1.2 Product Analysis                   

                                9.1.3 Financial analysis                  

                                9.1.4 Recent Developments                       

                                9.1.5 SWOT analysis                       

                                9.1.6 Analyst View                          

                9.2 Novartis                                       

                9.3 Pfizer   

                9.4 Mylan Laboratories                                 

                9.5 Amgen

                9.6 Merck & Co.                               

                9.7 Bayer   

                9.8 Eli Lily & Company                                  

                9.9 Novo Nordisk   

                9.10 Wyeth                                        

                9.11 F. Hoffmann-La Roche

                9.12 Hisamitsu Pharmaceutical  Co. Inc.                                 

10.Competitive Landscape                 

                10.1 Market share analysis 

                10.2 Merger and Acquisition Analysis                                     

                10.3 Agreements, collaborations and Joint Ventures                                       

                10.4 New Product Launches                                       

11.Expert Opinions                

                11.1 Market Outlook                                     

                11.2 Investment Opportunities                                 

Appendix                  

                a) List of Tables                                

                b) List of Figures     

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Hormone Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  2. Middle East & Africa Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  3. Middle East & Africa Estrogen Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  4. Middle East & Africa Growth Hormone Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  5. Middle East & Africa Thyroid Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  6. Middle East & Africa Other Hormone Therapies Market By Region, From 2021 to 2026 (USD Billion)
  7. Middle East Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  8. Middle East Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  9. Africa Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  10. Africa Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample